WSJ writes "Why Investors Were Right to Be Wary of Blue Owl’s $1.4 Billion Deal"

The WSJ's commentary suggests skepticism about Blue Owl's $1.4 billion deal, indicating potential concerns over valuation or strategic fit. Investors wary of such large mergers may see it as a signal that the deal's merits aren't fully convincing, possibly affecting Blue Owl's stock performance and investor sentiment. This scrutiny could lead to increased volatility in the stock as the market reevaluates the implications of the acquisition.